γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors

Cells will be extracted from a healthy donor, followed by ex-vivo expansion, activation and genetic engineering. The ex-vivo expanded γδ T-PD-1 Ab cells will be adoptively transfused to tumor patients.